Page 3 - சுவாதி பரத்வாஜ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சுவாதி பரத்வாஜ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சுவாதி பரத்வாஜ் Today - Breaking & Trending Today

'No one can speed up vaccine trials, and their evaluation' | India News


As the founder of Shantha Biotechnics, one of the first Indian companies to develop vaccines indigenously and the only one to develop a vaccine independently, K I Varaprasad Reddy has a unique insight into the ongoing global race to launch a Covid-19 vaccine. In an interview with Swati Bharadwaj, the Padma Bhushan awardee talks about the challenges ahead
It takes years to develop a vaccine but now the process is being fast-tracked. Are you worried that safety is being compromised?
Everyone knows that no vaccine was ever developed this fast. TB vaccine took 28 years, Ebola took 5.5 years. AIDS, though known for 40 years, does not have a vaccine as yet. Yes, technological advancement in virology and experiments with repurposed vaccines speeded up the development of this vaccine but no one can speed up clinical trials and their evaluation. A car can be designed to go at 300 km/hr speed. Still we fix a 100/120 speed limit on Indian roads because our road tests say so. Similarl ....

Andhra Pradesh , Padma Bhushan , Shantha Biotechnics , Swati Bharadwaj , Ki Varaprasad Reddy , National Testing Laboratory , Emergency Authorisation , ஆந்திரா பிரதேஷ் , பத்மா பூஷன் , சுவாதி பரத்வாஜ் , கி வரப்பிரசாத் சிவப்பு , தேசிய சோதனை ஆய்வகம் ,

'No one can speed up vaccine trials, and their evaluation' | Hyderabad News


K I Varaprasad Reddy
HYDERABAD: As the founder of Shantha Biotechnics, one of the first Indian companies to develop vaccines indigenously and the only one to have developed a vaccine independently, K I Varaprasad Reddy has a unique insight into the ongoing global race to launch a Covid-19 vaccine. In an interview with Swati Bharadwaj, the Padma Bhushan awardee talks about the challenges ahead.
The world is looking to India and vaccine capital Hyderabad to churn out Covid vaccines. What challenges do Indian vaccine makers face?
Let us be clear on one point. India has not produced any original vaccine so far, except for Cholera by Shantha Biotech. What we have here is robust infrastructure to manufacture vaccines in bulk. If someone hands us over a good vaccine, we can produce them in large quantities at an affordable cost so that even third world countries can buy it. The challenge Indian vaccine makers face is how to keep producing other ongoing vaccines with the same ....

Andhra Pradesh , Padma Bhushan , Shantha Biotechnics , Michael Yeadon , Swati Bharadwaj , Ki Varaprasad Reddy , National Testing Laboratory , Emergency Authorization , ஆந்திரா பிரதேஷ் , பத்மா பூஷன் , மைக்கேல் யெடொந் , சுவாதி பரத்வாஜ் , கி வரப்பிரசாத் சிவப்பு , தேசிய சோதனை ஆய்வகம் , அவசரம் அங்கீகாரம் ,

'No one can speed up vaccine trials, and their evaluation' | India News


As the founder of Shantha Biotechnics, one of the first Indian companies to develop vaccines indigenously and the only one to develop a vaccine independently, KI Varaprasad Reddy has a unique insight into the ongoing global race to launch a Covid-19 vaccine. In an interview with Swati Bharadwaj, the Padma Bhushan awardee talks about the challenges ahead
It takes years to develop a vaccine but now the process is being fast-tracked. Are you worried that safety is being compromised?
Everyone knows that no vaccine was ever developed this fast. TB vaccine took 28 years, Ebola took 5.5 years. AIDS, though known for 40 years, does not have a vaccine as yet. Yes, technological advancement in virology and experiments with repurposed vaccines speeded up the development of this vaccine but no one can speed up clinical trials and their evaluation. A car can be designed to go at 300 km/hr speed. Still we fix a 100/120 speed limit on Indian roads because our road tests say so. Similarly ....

Andhra Pradesh , Padma Bhushan , Varaprasad Reddy , Shantha Biotechnics , Swati Bharadwaj , National Testing Laboratory , Emergency Authorisation , ஆந்திரா பிரதேஷ் , பத்மா பூஷன் , வரப்பிரசாத் சிவப்பு , சுவாதி பரத்வாஜ் , தேசிய சோதனை ஆய்வகம் ,